Revascularization Strategy in Myocardial Infarction with Multivessel Disease

The proportion of patients with multivessel coronary artery disease in individuals experiencing acute coronary syndrome (ACS) varies based on age and ACS subtype. In patients with ST-segment elevation myocardial infarction (STEMI) without cardiogenic shock, the prognostic benefit of complete revascularization has been demonstrated by several randomized trials and meta-analyses, leading to a strong guideline recommendation. However, similar data are lacking for ACS without ST-segment elevation (NSTE-ACS). Non-randomized data suggesting a benefit from complete revascularization in non-ST-segment elevation myocardial infarction (NSTEMI) are prone to selection bias and should be interpreted with caution. A series of large randomized controlled trials have been initiated recently to address these open questions.

[1]  Min Chul Kim,et al.  Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve–Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy , 2023, Circulation. Cardiovascular interventions.

[2]  A. Greco,et al.  Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic Review. , 2023, JACC. Cardiovascular interventions.

[3]  W. Rottbauer,et al.  Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2023, The New England journal of medicine.

[4]  D. Dudek,et al.  Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction. , 2023, The New England journal of medicine.

[5]  B. Lewis,et al.  2023 ESC Guidelines for the management of acute coronary syndromes. , 2023, European heart journal.

[6]  E. Boersma,et al.  Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial , 2023, The Lancet.

[7]  N. Van Mieghem,et al.  Comparison of plug-based versus suture-based vascular closure for large-bore arterial access: a collaborative meta-analysis of observational and randomized studies , 2023, Clinical Research in Cardiology.

[8]  Min Chul Kim,et al.  Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. , 2022, European heart journal.

[9]  Sunil V. Rao,et al.  Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. , 2022, JAMA cardiology.

[10]  G. Chatellier,et al.  Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. , 2021, The New England journal of medicine.

[11]  J. Cairns,et al.  Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction , 2020, Circulation. Cardiovascular interventions.

[12]  A. M. Leone,et al.  Fractional Flow Reserve or Optical Coherence Tomography to Guide Management of Angiographically Intermediate Coronary Stenosis: A Single-Center Trial. , 2020, JACC. Cardiovascular interventions.

[13]  M. Keltai,et al.  Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. , 2019, Journal of the American College of Cardiology.

[14]  N. Lakkis,et al.  Meta-analysis Comparing Multivessel Versus Culprit Coronary Arterial Revascularization for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. , 2019, American Journal of Cardiology.

[15]  Á. Avezum,et al.  Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.

[16]  J. Davies,et al.  Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction. , 2019, JAMA cardiology.

[17]  Ajay K. Jain,et al.  Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes. , 2018, Journal of the American College of Cardiology.

[18]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[19]  G. Rodriguez-Granillo,et al.  Letter by Rodriguez-Granillo et al Regarding Article, "Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015". , 2018, Circulation.

[20]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[21]  E. Vicaut,et al.  Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials , 2017, The Lancet.

[22]  F. Neumann,et al.  Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.

[23]  F. Fedele,et al.  Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. , 2016, Journal of the American College of Cardiology.

[24]  L. Køber,et al.  Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.

[25]  A. M. Leone,et al.  Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. , 2015, European heart journal.

[26]  H. Swanton,et al.  Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.

[27]  R. Califf,et al.  Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. , 2014, JAMA.

[28]  R. Califf,et al.  EXTENT, LOCATION, AND CLINICAL SIGNIFICANCE OF NON-INFARCT RELATED CORONARY ARTERY DISEASE AMONG PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION , 2014 .

[29]  Bo Yu,et al.  In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. , 2013, Journal of the American College of Cardiology.

[30]  C. Berry,et al.  Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.

[31]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[32]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[33]  Deepak L. Bhatt,et al.  Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.